Skip to main content
  • an Accelerating Medicines Partnership® (AMP®) program
Register Workbench

NEI Main Menu

  • Register Workbench
  • About
      • About AMP PD
      • AMP PD Use Cases
      • Contact Us
      • Glossary
      • Who we are
      • Contributor Spotlights
  • News & Updates
      • News & Updates
      • Release Updates
      • AMP PD Research Plan
      • News & Articles Archive
  • Data
      • Data
      • Harmonized Data
        • Summary Data Dashboard
        • Whole Genome Data
        • Transcriptomics Data
        • Targeted Proteomics Data
        • Clinical Assessment Data
      • Federated Data
        • GP2 Cohort Dashboard
        • Genomic Data
  • Cohorts
      • Cohorts
      • Unified Cohorts
        • BioFIND
        • HBS
        • LBD
        • LCC
        • PDBP
        • PPMI
        • STEADY-PD3
        • SURE-PD3
      • Federated Cohorts
        • GP2
  • Tools
      • Terra Platform
      • SmartConverter Data Curation
      • Visualization Tools & Resources
  • Researchers
      • Knowledge Platform Governance
      • Register for AMP PD
      • Data Use Agreement
  • Portal Resources
      • How To & References
      • AMP PD Webinar
      • Cloud Cost Guidelines
      • Cloud Architecture
      • Computing Guidelines
  • FAQs
Register Workbench
  • < Back To Home
  • /
  • News & Updates

News & Updates

Learn about the research and successes of AMP PD and the cohorts, grant-funding opportunities for Parkinson’s disease researchers, and portal updates.

Data Releases & Portal Updates

May 16, 2022

GP2 Release Notes – May 2022

May 12, 2022

AMP PD Release Notes - May 2022

December 17, 2021

GP2 Release Notes – December 2021

View all releases & updates

Recent Articles

July 22, 2022

AMP PD has launched its first Community Workspace on the AMP PD Knowledge Platform

July 22, 2022

AMP PD has launched a public webinar series to showcase AMP PD workspaces in Terra

May 31, 2022

Heterozygous PRKN mutations are common but do not increase the risk of Parkinson’s disease

View all articles

Recent Abstracts

July 27, 2020

Biomarker Discovery in Parkinson’s disease using Machine Learning on Public Multi-omic Datasets: A Pilot Study

View all abstracts
ACCELERATING MEDICINES PARTNERSHIP and AMP are registered service marks of the U.S. Department of Health and Human Services.

Footer Links

  • Contact us
  • Policy & Governance
  • Privacy Statement
  • Disclaimer
  • Site Map
  • Accessibility Policy
  • Reuse & Copyright
  • Glossary